0.60

0.00% 0.00

After Hours: .60

VolitionRX Ltd (VNRX)

Overview News Price History Option Chain Discussions Forecast

VolitionRX Ltd stock is traded at $0.60, with a volume of 85,036. It is up +0.00% in the last 24 hours and down -32.05% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Previous Close:

$0.60

Open:

$0.59

24h Volume:

85,036

Relative Volume:

0.65

Market Cap:

$55.26M

Revenue:

$775.30K

Net Income/Loss:

$-35.32M

P/E Ratio:

-1.0714

EPS:

-0.56

Net Cash Flow:

$-19.15M

1W Performance:

+0.81%

1M Performance:

-32.05%

6M Performance:

-32.65%

1Y Performance:

-25.84%

1-Day Range:

$0.5863

$0.65

1-Week Range:

$0.55

$0.65

52-Week Range:

$0.4301

$1.23

VolitionRX Ltd Stock (VNRX) Company Profile

Name

VolitionRX Ltd

Sector

Healthcare (1181)

Industry

Diagnostics & Research (57)

Phone

646 650 1351

Address

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Employee

Twitter

@VolitionRx

Next Earnings Date

2024-11-12

Latest SEC Filings

VNRX's Discussions on Twitter

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-01-23	Downgrade	The Benchmark Company	Buy → Hold
Feb-17-22	Resumed	Cantor Fitzgerald	Overweight
Mar-10-21	Initiated	Cantor Fitzgerald	Overweight
May-16-18	Initiated	Maxim Group	Buy
May-14-18	Reiterated	The Benchmark Company	Buy
Sep-07-16	Reiterated	Rodman & Renshaw	Buy
Feb-01-16	Initiated	Rodman & Renshaw	Buy

View All

VolitionRX Ltd Stock (VNRX) Latest News

Nov 04, 2024

VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - Defense World

Nov 04, 2024

Oct 27, 2024

VolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.com - Defense World

Oct 27, 2024

Oct 09, 2024

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar - Quantisnow

Oct 09, 2024

Sep 30, 2024

VolitionRx adds Dr. Ethel Rubin to its board By Investing.com - Investing.com South Africa

Sep 30, 2024

Agency News | ⚡Tamil Nadu’s Veterinary Varsity Directed by High Court To Consider Transgender Student’s Application - LatestLY

Sep 18, 2024

Madras HC directs TN veterinary varsity to not reject transgender's application over identity - Hindustan Times

Sep 18, 2024

Madras High Court Orders TN Veterinary University to Accept Transgender Candidate's Application - Law Trend

Sep 18, 2024

Don't reject transgender's application over identity HC tells TN veterinary varsity - The Week

Sep 18, 2024

Madras High Court Upholds Transgender Rights for Veterinary Course Admissions - Devdiscourse

Sep 18, 2024

Sep 17, 2024

Volato Facing Class-action WARN Act Lawsuit - Aviation International News

Sep 17, 2024

VolitionRx offers oncology assets for licensing - Investing.com India

Sep 17, 2024

VolitionRx offers oncology assets for licensing By Investing.com - Investing.com Australia

Sep 17, 2024

Sep 16, 2024

Volition Announces Board of Directors - TechBuzz News

Sep 16, 2024

Sep 14, 2024

CRYPTOPSY's New Shirts Are Very Serious - Metal Injection

Sep 14, 2024

Sep 13, 2024

Terminated Volato Employees File Class Action Lawsuit - FLYING

Sep 13, 2024

Sep 12, 2024

LifeLabs workers in GTA poised to strike if deal not reached by Saturday - CP24

Sep 12, 2024

Sep 11, 2024

Investing in VolitionRX Ltd (VNRX): What You Must Know - Knox Daily

Sep 11, 2024

Volition Hosts KOL Roundtable on Sepsis - Yahoo Finance

Sep 11, 2024

Sep 05, 2024